These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27581061)

  • 1. Myostatin inhibition therapy for insulin-deficient type 1 diabetes.
    Coleman SK; Rebalka IA; D'Souza DM; Deodhare N; Desjardins EM; Hawke TJ
    Sci Rep; 2016 Sep; 6():32495. PubMed ID: 27581061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
    Mas A; Montané J; Anguela XM; Muñoz S; Douar AM; Riu E; Otaegui P; Bosch F
    Diabetes; 2006 Jun; 55(6):1546-53. PubMed ID: 16731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
    Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
    Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus polysaccharide suppresses skeletal muscle myostatin expression in diabetes: involvement of ROS-ERK and NF-κB pathways.
    Liu M; Qin J; Hao Y; Liu M; Luo J; Luo T; Wei L
    Oxid Med Cell Longev; 2013; 2013():782497. PubMed ID: 24454989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin.
    Chen Y; Cao L; Ye J; Zhu D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):112-6. PubMed ID: 19646957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of rAAV-Mediated Expression of Myostatin Propeptide Lowers Type 2 Diabetes Incidence in
    Yan H; Meng J; Zhang S; Zhuang H; Song Y; Xiao X; Wang DW; Jiang J
    Hum Gene Ther; 2019 May; 30(5):661-671. PubMed ID: 30526118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal muscle glucose uptake in mice deficient in muscle GLUT4.
    Fam BC; Rose LJ; Sgambellone R; Ruan Z; Proietto J; Andrikopoulos S
    J Endocrinol; 2012 Sep; 214(3):313-27. PubMed ID: 22736482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway.
    Zhang C; McFarlane C; Lokireddy S; Bonala S; Ge X; Masuda S; Gluckman PD; Sharma M; Kambadur R
    Diabetologia; 2011 Jun; 54(6):1491-501. PubMed ID: 21347623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced skeletal muscle growth in myostatin-deficient transgenic pigs had improved glucose uptake in stretozotocin-induced diabetes.
    Li B; Cui W; Yang J
    Transgenic Res; 2020 Apr; 29(2):253-261. PubMed ID: 32078127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus-mediated expression of myostatin propeptide improves the growth of skeletal muscle and attenuates hyperglycemia in db/db mice.
    Jiang JG; Shen GF; Li J; Qiao C; Xiao B; Yan H; Wang DW; Xiao X
    Gene Ther; 2017 Mar; 24(3):167-175. PubMed ID: 27983718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
    Krause MP; Riddell MC; Gordon CS; Imam SA; Cafarelli E; Hawke TJ
    J Appl Physiol (1985); 2009 May; 106(5):1650-9. PubMed ID: 19246652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1-PI3K-AKT signaling pathway and GLUT4 expression.
    Guo X; Sun W; Luo G; Wu L; Xu G; Hou D; Hou Y; Guo X; Mu X; Qin L; Liu T
    FEBS Open Bio; 2019 May; 9(5):1008-1019. PubMed ID: 30945455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin alters glucose transporter-4 (GLUT4) expression in bovine skeletal muscles and myoblasts isolated from double-muscled (DM) and normal-muscled (NM) Japanese shorthorn cattle.
    Takahashi H; Sato K; Yamaguchi T; Miyake M; Watanabe H; Nagasawa Y; Kitagawa E; Terada S; Urakawa M; Rose MT; McMahon CD; Watanabe K; Ohwada S; Gotoh T; Aso H
    Domest Anim Endocrinol; 2014 Jul; 48():62-8. PubMed ID: 24906930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
    Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimonanthus nitens Oliv. leaf extract exerting anti-hyperglycemic activity by modulating GLUT4 and GLUT1 in the skeletal muscle of a diabetic mouse model.
    Chen H; Xiong L; Wang N; Liu X; Hu W; Yang Z; Jiang Y; Zheng G; Ouyang K; Wang W
    Food Funct; 2018 Sep; 9(9):4959-4967. PubMed ID: 30182103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.
    Riu E; Mas A; Ferre T; Pujol A; Gros L; Otaegui P; Montoliu L; Bosch F
    Diabetes; 2002 Mar; 51(3):704-11. PubMed ID: 11872670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal.
    Cleasby ME; Jarmin S; Eilers W; Elashry M; Andersen DK; Dickson G; Foster K
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E814-23. PubMed ID: 24473441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
    Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
    Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.